Sugammadex is an effective and increasingly popular agent for reversing rocuronium-induced neuromuscular blockade in anesthesia and critical care, offering advantages over neostigmine.
May inform reversal selection in anesthesia; leaves open cost-effectiveness and critical care outcome trials.
The purpose of this update is to provide recent knowledge and debates regarding the use of sugammadex in the fields of anesthesia and critical care. The review is not intended to provide a comprehensive description of sugammadex and its clinical use.
No takes yet. Share an insight, caveat, or question.
Ezri et al. (2016) conducted a review in Neuromuscular blockade. Sugammadex vs. Neostigmine was evaluated.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: